Journeys

RECAP: Rare Disease Week on Capitol Hill

More than 800 members of the rare disease community, including 12 passionate individuals living with LAM and their families, teamed up for Rare Disease Week

RECAP: Rare Disease Week on Capitol Hill

Study: Potential New Avenue for Treating LAM

The loss of the TSC2 gene, either inherited or sporadic, can lead to pulmonary lymphangioleiomyomatosis (LAM), a rare lung disease characterized by cystic growths caused

Study: Potential New Avenue for Treating LAM

CpG-ODN as novel LAM immunotherapy

Lymphangioleiomyomatosis (LAM) is a rare but serious lung disease mostly affecting women of reproductive age. LAM leads to lung damage through the formation of cysts.

CpG-ODN as novel LAM immunotherapy

Assessing Unsupervised Exercise in Interstitial Lung Disease

Patients with interstitial lung diseases (ILDs), including lymphangioleiomyomatosis (LAM), have unique risks for adverse health events during exercise training outside of a medically supervised setting.

Assessing Unsupervised Exercise in Interstitial Lung Disease
Menu